Reevaluating the role of dilation and curettage in the diagnosis of pregnancy of unknown location

Fertil Steril. 2011 Sep;96(3):659-62. doi: 10.1016/j.fertnstert.2011.06.017. Epub 2011 Jul 5.

Abstract

Objective: To evaluate the clinical utility of dilation and curettage (D&C) in diagnosing ectopic pregnancy (EP).

Design: Retrospective cohort study.

Setting: University hospital.

Patient(s): Clinically stable women (n = 321) who underwent a diagnostic D&C with no visible intrauterine pregnancy (IUP) on transvaginal ultrasound or those with an abnormal hCG trend.

Intervention(s): None.

Main outcome measure(s): EP or IUP made by final pathologic review.

Result(s): Overall, 73.2% of the patients were ultimately diagnosed with EP and 26.8% were found to have a nonviable IUP. Those with EPs had significantly lower initial hCGs than those with nonviable IUPs and were more likely to have had a history of an EP. On ultrasound, the overall impression, the presence of free fluid, and the endometrial echo complex correlated well with the final diagnoses but did not have 100% predictive value.

Conclusion(s): D&C remains valuable to differentiate EP from nonviable IUP and to avoid misdiagnosis and unnecessary exposure to methotrexate. Low initial hCG values and ultrasound findings such as a thin endometrial echo complex and the presence of free fluid are associated with but are not diagnostic of an ectopic pregnancy.

MeSH terms

  • Abortifacient Agents, Nonsteroidal / therapeutic use
  • Adolescent
  • Adult
  • Chorionic Gonadotropin / metabolism
  • Cohort Studies
  • Diagnostic Errors / prevention & control*
  • Diagnostic Techniques, Obstetrical and Gynecological*
  • Dilatation and Curettage / methods*
  • Female
  • Humans
  • Methotrexate / therapeutic use
  • Middle Aged
  • Pregnancy
  • Pregnancy, Ectopic / diagnosis*
  • Pregnancy, Ectopic / diagnostic imaging
  • Pregnancy, Ectopic / metabolism
  • Retrospective Studies
  • Ultrasonography
  • Young Adult

Substances

  • Abortifacient Agents, Nonsteroidal
  • Chorionic Gonadotropin
  • Methotrexate